Cargando…
Patient-reported adherence to coprescribed proton pump inhibitor gastroprotection in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis patients using nonsteroidal anti-inflammatory drugs
BACKGROUND: Patients with osteoarthritis (OA), rheumatoid arthritis (RA), or ankylosing spondylitis (AS) are commonly treated with nonsteroidal anti-inflammatory drugs (NSAIDs), sometimes with a concomitant gastroprotective proton pump inhibitor (PPI). The present study examines real-life patient ad...
Autores principales: | Henriksson, Kenneth, From, Jesper, Stratelis, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242701/ https://www.ncbi.nlm.nih.gov/pubmed/25429206 http://dx.doi.org/10.2147/PPA.S70651 |
Ejemplares similares
-
Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits
por: Gwee, Kok Ann, et al.
Publicado: (2018) -
Are nonsteroidal anti-inflammatory drugs safe for the kidney in ankylosing spondylitis?
por: Kim, Ji-Won
Publicado: (2023) -
Editorial The Role of Surgery in Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis
por: W.S, Khan, et al.
Publicado: (2015) -
Adherence to coprescribing of laxatives with opioids and associated characteristics in general practices in the Netherlands
por: Hek, Karin, et al.
Publicado: (2022) -
Does coprescribing nonsteroidal anti‐inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism?
por: Penner, Leonie S., et al.
Publicado: (2022)